New research results from a COAPT study examined the effect MitraClip had on heart failure patients.
New research results from a COAPT study examined the effect MitraClip had on heart failure patients.
Liver disease is the eighth leading cause of death in the United States and the third or fourth leading cause of death among patients 45 to 64. To improve these outcomes, many hepatologists on the medical staffs of Baylor University Medical Center at Dallas and Baylor Scott & White All Saints Medical Center – Fort Worth are undertaking a number of notable patient-centered research projects. All research projects are administered by Baylor Scott & White Research Institute.
Baylor Scott & White Medical Center in Temple has opened enrollment on a study designed to help characterize the prevalence and distribution of lipoprotein(a) Lp(a), levels among patients with established cardiovascular disease (CVD).
Baylor Scott & White Heart & Vascular Hospital – Dallas is currently enrolling patients for a prospective, multicenter, single-arm, global investigational device exemption (IDE) study to evaluate the safety and effectiveness of the Shockwave Coronary IVL System in de novo, calcified, stenotic coronary arteries prior to stenting. Disrupt CAD III is being conducted as a staged pivotal study.
Baylor Scott & White All Saints Medical Center – Fort Worth is currently enrolling patients for a study designed to assess the impact of the Multi Point Pacing (MPP) feature at 12 months in the treatment of patients not responding to standard Cardiac Resynchronization Therapy (CRT) after 6 months.